Search

everythinglearnresearchcommunity

for

Search:↓

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Basal cell carcinomas need extra mutations to grow from small to large tumors.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

Scalp basal cell carcinoma may be more aggressive and harder to treat than other types, requiring special attention and further research.

A rare type of skin cancer on the scalp can be mistaken for hair loss, causing delayed diagnosis and severe damage.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Nonmelanoma skin cancers have higher levels of certain osteopontin variants than normal skin.

Dr. Zitelli emphasized that "Mohs surgery" should only be called that when one doctor does both the surgery and pathology.

Laser and light technologies are used in dermatology for skin treatments and improving outcomes.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

A rare skin condition was identified and planned for treatment in an elderly man.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

Understanding where cancer cells come from helps create better prevention and treatment methods.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Deep learning helps detect skin conditions and is advancing dermatology diagnosis and treatment.

The Hedgehog Signaling Pathway is important for skin and hair development and skin cancer treatment, but more research is needed to understand it fully.

The meeting discussed various skin conditions, treatments, and unusual cases, highlighting the effectiveness of tetracycline in treating rosacea.

Autoimmune conditions can be linked to trichoepitheliomas, with treatment focusing on cosmetic concerns.

BSSP may help skin tumors grow and could be a marker or target for skin cancer treatment.